Clinical trial
Phase II Study of [18F]RGD-K5 in Head and Neck Cancer Patients
NCT01447134 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of [18F]RGD-K5 in Head and Neck Cancer Patients
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2011
- Completion date
- June 30, 2014
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.